Australia markets closed

Purple Biotech Ltd (PPBT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.5242-0.0134 (-2.49%)
At close: 03:57PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 13.99M
Enterprise value -1.07M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.40
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.57
52-week change 3-71.25%
S&P500 52-week change 326.43%
52-week high 31.9900
52-week low 30.3020
50-day moving average 30.6361
200-day moving average 30.9197

Share statistics

Avg vol (3-month) 3152.7k
Avg vol (10-day) 3128.05k
Shares outstanding 526.11M
Implied shares outstanding 628.01M
Float 8235.12M
% held by insiders 13.85%
% held by institutions 18.20%
Shares short (15 Apr 2024) 4222.22k
Short ratio (15 Apr 2024) 42.89
Short % of float (15 Apr 2024) 4N/A
Short % of shares outstanding (15 Apr 2024) 40.90%
Shares short (prior month 15 Mar 2024) 4223k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 321 Aug 2020
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 321 Aug 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-28.14%
Return on equity (ttm)-49.09%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -22.23M
Net income avi to common (ttm)-19.88M
Diluted EPS (ttm)-0.9000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)15.41M
Total cash per share (mrq)0.06
Total debt (mrq)351k
Total debt/equity (mrq)1.02%
Current ratio (mrq)2.20
Book value per share (mrq)0.14

Cash flow statement

Operating cash flow (ttm)-19.93M
Levered free cash flow (ttm)-10.95M